← Leaderboards
Tamara Minko
Rutgers Biomedical And Health Sciences
$15,557,982
Attributed
$15,557,982
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,557,982 · 8
By mechanism
R01$14,232,231 · 7
U54$1,325,751 · 1
Top collaborators
No co-investigators on record.
Most similar at Rutgers Biomedical And Health Sciences
Same institution · by research overlap
- Xiaofeng Steven Zheng$14,999,123
- Monica J Roth$14,970,765
Others in their field
Top investigators on “Drug Delivery Systems”
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
- Myron S Cohen · Family Health International$101,800,876
- Gerald Van Belle · University Of Washington$48,120,734
- David Heimbrook · Leidos Biomedical Research, Inc.$47,325,954
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$38,382,452
- Martin Friedlander · Scripps Research Institute$36,319,942
Research focus
Drug Delivery SystemsCancer CellOrganAntineoplastic AgentsChemotherapyMalignant NeoplasmsInvestigationIn VivoSmall Interfering RnaResistanceTumorPharmaceutical PreparationsDrug ResistanceCell Death InductionPrimary NeoplasmBaseDesignNeoplasm MetastasisProteinsOverexpressionNanotechnologyAdverse EffectsPreventMalignant Neoplasm Of Ovary
Grant awards (39)
Nanotechnology-based personalized treatment of metastatic ovarian cancer$618,404
R01 · FY2025 · CA · contact PI
Nanotechnology-based personalized treatment of metastatic ovarian cancer$587,799
R01 · FY2024 · CA · contact PI
Nanotechnology-based personalized treatment of metastatic ovarian cancer$605,511
R01 · FY2023 · CA · contact PI
Bionanotechnology approach for treatment of lung cancer$581,249
R01 · FY2023 · CA · contact PI
Nanotechnology-based personalized treatment of metastatic ovarian cancer$617,999
R01 · FY2022 · CA · contact PI
Bionanotechnology approach for treatment of lung cancer$573,870
R01 · FY2022 · CA · contact PI
Bionanotechnology approach for treatment of lung cancer$585,581
R01 · FY2021 · CA · contact PI
Tumor-targeted nanoparticle-based delivery system for imaging and treatment of cancer$441,713
R01 · FY2021 · CA · contact PI
Bionanotechnology approach for treatment of lung cancer$585,581
R01 · FY2020 · CA · contact PI
Tumor-targeted nanoparticle-based delivery system for imaging and treatment of cancer$449,103
R01 · FY2020 · CA · contact PI
Bionanotechnology approach for treatment of lung cancer$585,581
R01 · FY2019 · CA · contact PI
Tumor-targeted nanoparticle-based delivery system for imaging and treatment of cancer$442,589
R01 · FY2019 · CA · contact PI
Tumor-targeted nanoparticle-based delivery system for imaging and treatment of cancer$463,244
R01 · FY2018 · CA · contact PI
Tumor-targeted nanoparticle-based delivery system for imaging and treatment of cancer$470,010
R01 · FY2017 · CA · contact PI
Nanotechnology Approach for Inhalation Treatment of Pulmonary Fibrosis$465,656
R01 · FY2017 · HL · contact PI
Nanotechnology Approach for Inhalation Treatment of Pulmonary Fibrosis$470,334
R01 · FY2016 · HL · contact PI
Nanotechnology Approach for Inhalation Treatment of Pulmonary Fibrosis$467,743
R01 · FY2015 · HL · contact PI
Nanotechnology Approach for Inhalation Treatment of Pulmonary Fibrosis$479,267
R01 · FY2014 · HL · contact PI
Multifunctional Nanotherapeutics for Cancer Treatment and Imaging$300,860
R01 · FY2014 · CA · contact PI
Combination Nanotherapeutic Strategies to Overcome Tumor Drug Resistance$254,447
U54 · FY2014 · CA · contact PI
Multifunctional Nanotherapeutics for Cancer Treatment and Imaging$291,555
R01 · FY2013 · CA · contact PI
Combination Nanotherapeutic Strategies to Overcome Tumor Drug Resistance$247,064
U54 · FY2013 · CA · contact PI
Multifunctional Nanotherapeutics for Cancer Treatment and Imaging$310,035
R01 · FY2012 · CA · contact PI
Combination Nanotherapeutic Strategies to Overcome Tumor Drug Resistance$266,219
U54 · FY2012 · CA · contact PI
Multifunctional Nanotherapeutics for Cancer Treatment and Imaging$307,721
R01 · FY2011 · CA · contact PI
Combination Nanotherapeutic Strategies to Overcome Tumor Drug Resistance$267,117
U54 · FY2011 · CA · contact PI
Targeted Proapoptotic Anticancer Drug Delivery Systems$424,329
R01 · FY2010 · CA · contact PI
Multifunctional Nanotherapeutics for Cancer Treatment and Imaging$329,466
R01 · FY2010 · CA · contact PI
Combination Nanotherapeutic Strategies to Overcome Tumor Drug Resistance$290,904
U54 · FY2010 · CA · contact PI
Molecular Targeting of Drug Delivery System to Cancer$266,286
R01 · FY2010 · CA · contact PI
Targeted Proapoptotic Anticancer Drug Delivery Systems$437,954
R01 · FY2009 · CA · contact PI
Molecular Targeting of Drug Delivery System to Cancer$266,286
R01 · FY2009 · CA · contact PI
Molecular Targeting of Drug Delivery System to Cancer$266,286
R01 · FY2008 · CA · contact PI
Molecular Targeting of Drug Delivery System to Cancer$265,997
R01 · FY2007 · CA · contact PI
Targeted Proapoptotic Anticancer Drug Delivery System$241,805
R01 · FY2007 · CA · contact PI
Molecular Targeting of Drug Delivery System to Cancer$273,350
R01 · FY2006 · CA · contact PI
Targeted Proapoptotic Anticancer Drug Delivery System$249,027
R01 · FY2006 · CA · contact PI
Targeted Proapoptotic Anticancer Drug Delivery System$255,020
R01 · FY2005 · CA
Targeted Proapoptotic Anticancer Drug Delivery System$255,020
R01 · FY2004 · CA